Occupational neurologic disorders in Korea

Journal of Clinical Neurology (Korea)

Volumn 6, Issue 2, 2010, Pages 64-72

  Kim, Yangho ^a   Jeong, Kyoung Sook ^b   Yun, Yong Hun ^c   Oh, Myoung Soon ^a  

^a University of Ulsan College of Medicine   (South Korea)

^b Dongguk University   (South Korea)

^c Korea Occupational Safety and Health Agency   (South Korea)

Author keywords

Neurologic disorders; Occupational disease; Toxicology

Indexed keywords

EID: 78651506790     PISSN: 17386586     EISSN: 20055013     Source Type: Journal    
DOI: 10.3988/jcn.2010.6.2.64     Document Type: Review

References (80)

1. US EPA. Toxic Substances Control Act (TSCA). Chemical substance inventory-revised inventory synonym and preferred name file. Washington, DC: Office of Pollution, Prevention, and Toxics, 2000.
2. Levin SM, Lilis R. Carbon disulfide. In: Rom WN, Markowitz SB. Environmental and Occupational Medicine. 4th ed. Philadelphia: Lippincott Williams & Wilkins, 2006;1219-1225.
3. Resenberg NL. Recognition and evaluation of work-related neurologic disorders. In: Resenberg NL. Occupational and Environmental Neurology. Boston: Butterworth-Heinemann, 1995;9-45.
4. Park J, Hisanaga N, Kim Y. Transfer of occupational health problems from a developed to a developing country: lessons from the Japan- South Korea experience. Am J Ind Med 2009;52:625-632.
5. Lee EI, Kim SD, Kim HJ, Kim KJ, Yum YT. Carbon disulfide poisoning in Korea with social and historical background. J Occup Health 1996;38:155-161.
6. Kim Y, Kim KS, Yang JS, Park IJ, Kim E, Jin Y, et al. Increase in signal intensities on T1-weighted magnetic resonance images in asymptomatic manganese-exposed workers. Neurotoxicology 1999;20: 901-907.
7. Shin JY, Leem JH, Kim YK, Park SG, Lee JN, Kim HC, et al. A case of peripheral polyneuropathy occurring in a small enterprise processing mobile phone cases. Korean J Occup Environ Med 2005;17:138-143.
8. Cho SI, Jhun HJ, Yim SH, Lee YK, Lee SY, Kim MJ, et al. Health evaluation of Korean carbon disulfide poisoned subjects after exposure has ceased. Seoul: Institute of Work. Environment and Health, 2005;13.
9. Lee KB, Byoun HJ, Choi TS, Cho WY, Kim HK. Clinical manifestation of chronic carbon disulfide intoxication. Korean J Int Med 1990; 39:245-251.
10. Choi JW, Jang SH. A review on the carbon disulfide poisoning experienced in Korean. Korean J Occup Environ Med 1991;3:11-20.
11. Kim DS, Kim SD, Cha CW. A study of the peripheral neuropathy among the workers exposed to carbon disulfide. Korean J Prev Med 1993;26:282-292.
12. Lee EI, Cha CW. Health status of workers exposed to carbon disulfide at a viscose rayon factory in Korea. Korean J Occup Environ Med 1992;4:20-31.
13. Park JT, Kim HJ, Yum YT, Paek DM. An analytic study on the effect of carbon disulfide on blood pressure. Korean J Prev Med 1994;27: 581-596.
14. Koo JR, Jeong SC, Kwon HM, Kim BS, Kwon YJ, Cho WY, et al. Renal symptoms and kidney biopsy findings of chronic CS2 intoxication. Korean J Int Med 1990;39:245-251.
15. Chuang WL, Huang CC, Chen CJ, Hsieh YC, Kuo HC, Shih TS. Carbon disulfide encephalopathy: cerebral microangiopathy. Neurotoxicology 2007;28:387-393.
16. Cha JH, Kim SS, Han H, Kim RH, Yim SH, Kim MJ. Brain MRI findings of carbon disulfide poisoning. Korean J Radiol 2002;3:158-162.
17. Lee E, Kim MH. Cerebral vasoreactivity by transcranial Doppler in carbon disulfide poisoning cases in Korea. J Korean Med Sci 1998;13: 645-651.
18. Miura T. Work and health in rayon and staple industry. In: Miura T. History of work and health. Vol 4. Kawasaki: Institute for Science of Labour, 1981;203-236.
19. Harada M. Gold and mercury. Tokyo: Kodansha, 2002.
20. Fitsanakis VA, Au C, Erikson KM, Aschner M. The effects of manganese on glutamate, dopamine and gamma-aminobutyric acid regulation. Neurochem Int 2006;48:426-433.
21. Lucchini R, Kim Y. Health Effects of Manganese. In: Max Vojtisek, Ram Prakash. Metals and Neurotoxicity. India: Society for Science and Environment, 2009;119-147.
22. Calne DB, Chu NS, Huang CC, Lu CS, Olanow W. Manganism and idiopathic parkinsonism: similarities and differences. Neurology 1994; 44:1583-1586.
23. Yamada M, Ohno S, Okayasu I, Okeda R, Hatakeyama S, Watanabe H, et al. Chronic manganese poisoning: a neuropathological study with determination of manganese distribution in the brain. Acta Neuropathol 1986;70:273-278.
24. Newland MC, Ceckler TL, Kordower JH, Weiss B. Visualizing manganese in the primate basal ganglia with magnetic resonance imaging. Exp Neurol 1989;106:251-258.
25. Nelson K, Golnick J, Korn T, Angle C. Manganese encephalopathy: utility of early magnetic resonance imaging. Br J Ind Med 1993;50: 510-513.
26. Kim Y, Kim JW, Ito K, Lim HS, Cheong HK, Kim JY, et al. Idiopathic parkinsonism with superimposed manganese exposure: utility of positron emission tomography. Neurotoxicology 1999;20:249-252.
27. Park J, Kim Y, JW Kim. High Signal Intensities on T1-Weighted MRI in the Spectrum of Manganese Symptomatology. In: Webster LR. Neurotoxicity syndrome. New York: Novapublisher, 2007;249-260.
28. Iregren A. Manganese neurotoxicity in industrial exposures: proof of effects, critical exposure level, and sensitive tests. Neurotoxicology 1999;20:315-323.
29. Zoni S, Albini E, Lucchini R. Neuropsychological testing for the assessment of manganese neurotoxicity: a review and a proposal. Am J Ind Med 2007;50:812-830.
30. Lim Y, Yim HW, Kim KA, Yun IG. Review on manganese poisoning. Korean J Occup Health 1991;30:13-18.
31. Park CY, Roh YM, Koo JW, Lee SH. Manganese exposure in ore crushing. Korean J Occup Environ Med 1991;3:111-118.
32. Kim Y, Kim JW, Ito K, Hisanaga N, Cheong HK, Kim KS, Moon Y. Positron emission tomography (PET) in differentiating manganism from idiopathic parkinsonism. J Occup Health 1999;41:91-94.
33. Kim Y. Neuroimaging in manganism. Neurotoxicology 2006;27:369-372.
34. Mena I, Marin O, Fuenzalida S, Cotzias GC. Chronic manganese poisoning. Clinical picture and manganese turnover. Neurology 1967; 17:128-136.
35. Rodier J. Manganese poisoning in Moroccan mines. Br J Ind Med 1955;12:21-35.
36. Kim Y. Kim JM, Kim JW. Yoo CI, Lee CR, Lee JH, et al. Dopamine transporter density is decreased in parkinsonian patients with a history of manganese exposure: what does it mean? Mov Disord 2002;17: 568-575.
37. World Health Organization. Chronic effects of organic solvents on the central nervous system and diagnostic criteria. Copenhagen: World Health Organization, 1985.
38. Baker EL, Seppalainen AM. Workshop on neurobehavioral effects of Solvents. Human aspects of solvent neurobehavioral effects. Neurotoxicology 1986;7:45-56.
39. World Health Organization. International Statistical Classification of Diseases and Related Health Problems, 10th Revision (ICD-10). Geneva: World Health Organization, 1992.
40. American Psychiatric Association. Diagnostic and statistical manual for mental disorders. 4th ed. Washington, DC: American Psychiatric Press, 1994.
41. Keski-Säntti P, Mäntylä R, Lamminen A, Hyvärinen HK, Sainio M. Magnetic resonance imaging in occupational chronic solvent encephalopathy. Int Arch Occup Environ Health 2009;82:595-602.
42. Cheon YH. Toxic encephalopathy in a worker exposed to organic solvents; a case report. Korean J Occup Environ Med 1991;3:216-219.
43. Kang SK, Rhee KY, Chung HK, Lee YJ. A case of demyelinating lesion in central nervous system due to organic solvents. Korean J Occup Environ Med 1992;4:110-117.
44. Kang SK. Occupational neurologic disease-chronic toxic encephalopathy. Industrial Health (monthly magazine by Korean Industrial Health Association) Apr. 2000:5-13.
45. Kim JH, Ryu SJ, Kim BG, Jhun HJ, Park JT, Kim HJ. A case of trichloroethylene intoxication with neuropsychiatric symptoms. Korean J Occup Environ Med 2008;20:54-61.
46. Kim EA. Occupational neurologic disease-chronic toxic encephalopathy. Industrial Health (monthly magazine by Korean Industrial Health Association) Feb. 2006:4-8.
47. Kim EA. Occupational neurologic disease-chronic solvent poisoning. Industrial Health (monthly magazine by Korean Industrial Health Association) Oct. 2005:5-9.
48. van der Hoek JA, Verberk MM, Hageman G. Criteria for solvent-induced chronic toxic encephalopathy: a systematic review. Int Arch Occup Environ Health 2000;73:362-368.
49. Kaukiainen A, Akila R, Martikainen R, Sainio M. Symptom screening in detection of occupational solvent-related encephalopathy. Int Arch Occup Environ Health 2009;82:343-355.
50. De Haro L, Gastaut JL, Jouglard J, Renacco E. Central and peripheral neurotoxic effects of chronic methyl bromide intoxication. J Toxicol Clin Toxicol 1997;35:29-34.
51. Geyer HL, Schaumburg HH, Herskovitz S. Methyl bromide intoxication causes reversible symmetric brainstem and cerebellar MRI lesions. Neurology 2005;64:1279-1281.
52. Lee HJ, Oh SW, Lee JS, Chae HJ, Moon JD. A case of polyneuropathy associated with methyl bromide intoxication. Korean J Occup Environ Med 2007;19:238-243.
53. Choi KD, Shin JH, Kim DS, Jung DS, Park KH, O CJ, et al. A case of chronic methyl bromide poisoning associated with cerebellar ataxia, polyneuropathy and optic neuropathy. J Korean Neurol Assoc 2002;20: 307-310.
54. Park HJ, Lee KM, Nam JK, Park NC. A case of erectile dysfunction associated with chronic methyl bromide intoxication. Int J Impot Res 2005;17:207-208.
55. Park TH, Kim JI, Son JE, Kim JK, Kim HS, Jung KY. Two case of neuropathy by methyl bromide intoxication during fumigation. Korean J Occup Environ Med 2000;12:547-553.
56. Lee JH, Chung WC, Choi SY, Park KH, Kim SW. A case of methyl bromide intoxication with continual residual neurologic symptoms. Korean J Int Med 1984;27:621-624.
57. Lee JH, Lee MS, Ahn SH, Seo GS, Kim HR, Choi SC, et al. 3 cases of acute methyl bromide intoxication. Korean J Int Med 1998;56: 432-435.
58. Kim YJ, Kim YH, Jeong KS, Sim CS, Choy NR, Kim JC, et al. A case of acute organotin poisoning. Korean J Occup Environ Med 2006; 18:255-262.
59. Kim SH, Yoo CI, Kwon JH, Bae JH, Weon YC, Kim Y. A case of cerebellar dysfunction after acute organotin poisoning. Korean J Occup Environ Med 2009;21:289-292.
60. Besser R, Krämer G, Thümler R, Bohl J, Gutmann L, Hopf HC. Acute trimethyltin limbic-cerebellar syndrome. Neurology 1987;37:945-950.
61. Feldman RG. Occupational neurology. Yale J Biol Med 1987;60:179-186.
62. Nebuchennykh M, Løseth S, Jorde R, Mellgren SI. Idiopathic polyneuropathy and impaired glucose metabolism in a Norwegian patient series. Eur J Neurol 2008;15:810-816.
63. Kiel BD. Polyneuritis for n-hexane poisoning in rubber industries. J RIMSH 1974;6:423-429.
64. Occupational Safety and Health Research Institute (OSHRI). Peripheral neuropathy in workers exposed to n-hexane in a LCD frame manufacturer. OSHRI. Korea, 2005.
65. Kim EA. Occupational neurologic disease-peripheral neuropathy. Industrial Health (monthly magazine by Korean Industrial Health Association) May 2005:4-9.
66. Cho SY, Jang YS, Choi EK, Kim JS, Yu JY, Woo KH, et al. A case of peripheral polyneuropathy induced by occupational 2,5-hexanedione exposure. Korean J Occup Environ Med 2007;19:65-72.
67. Cheong HK, Kwon YW, Uh KY, Kim BJ, Yang JS, Jung C, et al. Polyneuropathy by occupational exposure to acrylamide. Korean J Occup Environ Med 1998;10:388-413.
68. Johnson FO, Atchison WD. The role of environmental mercury, lead and pesticide exposure in development of amyotrophic lateral sclerosis. Neurotoxicology 2009;30:761-765.
69. Oh SS, Kim EA, Lee SW, Kim MK, Kang SK. A case of amyotrophic lateral sclerosis in electronic parts manufacturing worker exposed to lead. Neurotoxicology 2007;28:324-327.
70. Kim EA. Occupational neurologic disease-amyotrophic lateral sclerosis. Industrial Health (monthly magazine by Korean Industrial Health Association) Dec. 2005:4-8.
71. Chancellor AM, Slattery JM, Fraser H, Warlow CP. Risk factors for motor neuron disease: a case-control study based on patients from the Scottish Motor Neuron Disease Register. J Neurol Neurosurg Psychiatry 1993;56:1200-1206.
72. McGuire V, Longstreth WT Jr, Nelson LM, Koepsell TD, Checkoway H, Morgan MS, et al. Occupational exposures and amyotrophic lateral sclerosis. A population-based case-control study. Am J Epidemiol 1997;145:1076-1088.
73. Weisskopf MG, Morozova N, O'Reilly EJ, McCullough ML, Calle EE, Thun MJ, et al. Prospective study of chemical exposures and amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 2009;80:558-561.
74. Jeong WS, Cheon JS, Chang HI. A case of organic mental disorder associated with subacute mercury poisoning. Korean J Neuropsych Assoc 1985;24:168-172.
75. Wee KS, Choi TS, Lee SJ, Cho WY, Kim HK. A clinical study of chronic mercury poisoning. Korean J Int Med 1990;38:51-57.
76. Kim BS, Hong YC, Lim HS, Kim JY, Lee JK, Huh BY. Four cases of chronic mercury poisoning. J Korean Acad Fam Med 1988;9:27-32.
77. Kim EA. Mercury poisong in wastes recycling workers. Industrial Health (monthly magazine by Korean Industrial Health Association) Apr. 2006:11-14.
78. Gregory AC 2nd, Shendell DG, Okosun IS, Gieseker KE. Multiple Sclerosis disease distribution and potential impact of environmental air pollutants in Georgia. Sci Total Environ 2008;396:42-51.
79. Gatley MS, Kelly GA, Turnbull IW. A case of organic solvent exposure and temporal lobe demyelination. J Soc Occup Med 1991;41:83-85.
80. Landtblom AM, Flodin U, Karlsson M, Pålhagen S, Axelson O, Soderfeldt B. Multiple sclerosis and exposure to solvents, ionizing radiation and animals. Scand J Work Environ Health 1993;19:399-404.